Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00027105 · ClinicalTrials.gov registry record

Morbidity Following the Diagnosis and Treatment of Patients With Breast Cancer

A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
165
Enrollment target

NCT00027105: Completed study, sponsored by National Institutes of Health Clinical Center (CC).

NCT00027105 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 165 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00027105 has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
165 participants
Enrollment target

Study Summary

This study will examine the frequency and severity of problems in women with breast cancer during the first year after initial medical treatment, including: * Physical impairments, such as loss of strength or flexibility, increased weight and swelling * Symptom distress, such as pain, fatigue and weakness. * Functional limitations and disabilities, such as loss of independence in activities of daily living (e.g., grooming, bathing, dressing, driving a car), work and social and recreational activities. It will identify factors associated with these problems and try to determine their relationship to them. Patients 18 years of age and older with stage I, II, III or IV breast cancer may be eligible for this study. Participants will be drawn from patients referred to the National Naval Medical Center for diagnosis and treatment during 2000-20001. Participants will be interviewed and their medical records reviewed for past medical history, history of the present illness and social and recreational history. They will be seen five times over a 1-year period (initial visit and at 3, 6, 9, and 12 months), for 30-minute visits, which will include the following: * Interview about past medical history and present illness, social and recreational activities, functional independence at work and during activities of daily living. * Complete health survey and upper limb disability questionnaire; physical activity questionnaire to be completed at 6 and 12 months after medical treatment begins. The questionnaires take about 30 to 40 minutes to complete. * Upper body examination, including pain measurement using a 10-point scale, an upper limb lift test, and measures of upper limb volume and girth.

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2001-11-16
Est. Completion 2016-08-17

What the finished NCT00027105 record still lists

NCT00027105 is an observational study that tracks outcomes without assigning an intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00027105 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00027105 about?

NCT00027105 is a clinical study titled "Morbidity Following the Diagnosis and Treatment of Patients With Breast Cancer". This study will examine the frequency and severity of problems in women with breast cancer during the first year after initial medical treatment, including: * Physical impairments, such as loss of strength or flexibility, increased weight and swelling * Symptom distress, such as pain, fatigue and w...

What is the current status of trial NCT00027105?

This trial is currently completed. The enrollment target is 165 participants. The study started on 2001-11-16. Estimated completion is 2016-08-17.

Who is sponsoring clinical trial NCT00027105?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02387255 · 165 participants

    Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms

  • NCT03351348 · 165 participants · Phase 3

    Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

  • NCT03830320 · 165 participants · Phase 1

    Positron Emission Tomography (PET) Imaging of Thrombosis

  • NCT04289571 · 165 participants · Phase 1

    Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00027105, the US trial registry maintained by the National Library of Medicine. NCT00027105 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.